High dose botulinum toxin A for the treatment of lower extremity hypertonicity in children with cerebral palsy

Developmental Medicine and Child Neurology

Volumn 49, Issue 11, 2007, Pages 818-822

  Willis, Allison W ^a   Crowner, Beth ^a   Brunstrom, Janice E ^a   Kissel, Abigail ^a   Racette, Brad A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; BENZODIAZEPINE; BOTULINUM TOXIN A; LEVODOPA;

ADOLESCENT; ADULT; ARTICLE; CEREBRAL PALSY; CHILD; CONTROLLED STUDY; DIARRHEA; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; FEVER; FLU LIKE SYNDROME; FOLLOW UP; HUMAN; IMMOBILIZATION; INFANT; INJECTION SITE CONTUSION; INJECTION SITE SWELLING; IRRITABILITY; LEG MUSCLE; MAJOR CLINICAL STUDY; MALAISE; MALE; MUSCLE HYPERTONIA; MUSCLE WEAKNESS; PATIENT CODING; PATIENT MOBILITY; PRIORITY JOURNAL; RANGE OF MOTION; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SEIZURE; SIDE EFFECT; TREATMENT DURATION; UNITED STATES; UNIVERSITY; WALKING AID;

BOTULINUM TOXIN TYPE A; CEREBRAL PALSY; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LOWER EXTREMITY; MALE; MUSCLE HYPERTONIA; MUSCLE, SKELETAL; NEUROMUSCULAR AGENTS; RETROSPECTIVE STUDIES;

EID: 35648944341     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2007.00818.x     Document Type: Article

References (20)

1. Marlow N, Wolke D, Bracewell MA, Samara M; EPICure Study Group. (2005) Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med 352: 9-19.
2. Koman LA, Mooney JF, Smith BP, Walker F, Leon JM. (2000) Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: A randomized, double-blind, placebo-controlled trial. BOTOX Study Group. J Pediatr Orthop 20: 108-115.
3. Corry IS, Cosgrove AP, Duffy CM, McNeill S, Taylor TC, Graham HK. (1998) Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: A randomised prospective trial. J Pediatr Orthop 18: 304-311.
4. Sutherland DH, Kaufman KR, Wyatt MP, Chambers HG, Mubarak SJ. (1999) Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy. Gait Posture 10: 1-9.
5. Ackman JD, Russman BS, Thomas SS, Buckon CE, Sussman MD, Masso P, Sanders J, D'Astous J, Aiona MD; Shriners Hospitals BTX-A Study Group. (2005) Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy. Dev Med Child Neurol 47: 620-627.
6. Chin TY, Nattrass GR, Selber P, Graham HK. (2005) Accuracy of intramuscular injection of botulinum toxin A in juvenile cerebral palsy: a comparison between manual needle placement and placement guided by electrical stimulation. J Pediatr Orthop 25: 286-291.
7. Jankovic J. (2001) Needle EMG guidance for injection of botulinum toxin. Needle EMG guidance is rarely required. Muscle Nerve 24: 1568-1570.
8. Baker R, Jasinski M, Maciag-Tymecka I, Michalowska-Mrozek J, Bonikowski M, Carr L, MacLean J, Lin JP, Lynch B, Theologis T, et al. (2002) Botulinum toxin treatment of spasticity in diplegic cerebral palsy: A randomized, double-blind, placebo-controlled, dose-ranging study. Dev Med Child Neurol 44: 666-675.
9. Heinen F, Schroeder AS, Fietzek U, Berweck S. (2006) When it comes to botulinum toxin, children and adults are not the same: Multimuscle option for children with cerebral palsy. Mov Disord 21: 2029-2030.
10. Goldstein EM. (2006) Safety of high-dose botulinum toxin type A therapy for the treatment of pediatric spasticity. J Child Neurol 21: 189-192.
11. Glanzman AM, Kim H, Swaminathan K, Beck T. (2004) Efficacy of botulinum toxin A, serial casting, and combined treatment for spastic equinus: A retrospective analysis. Dev Med Child Neurol 46: 807-811.
12. Mehrholz J, Wagner K, Meissner D, Grundmann K, Zange C, Koch R, Pohl M. (2005) Reliability of the Modified Tardieu Scale and the Modified Ashworth Scale in adult patients with severe brain injury: A comparison study. Clin Rehabil 19: 751-759.
13. Tardieu G, Shentoub S, Delarue R. (1954) Research on a technic for measurement of spasticity. Rev Neurol (Paris) 91: 143-144. (In French).
14. Ackman JD, Russman BS, Thomas SS, Buckon CE, Sussman MD, Masso P, Sanders J, D'Astous J, Aiona MD; Shriners Hospitals BTX-A Study Group. (2005) Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy. Dev Med Child Neurol 47: 620-627.
15. Glanzman AM, Kim H, Swaminathan K, Beck T. (2004) Efficacy of botulinum toxin A, serial casting, and combined treatment for spastic equinus: A retrospective analysis. Dev Med Child Neurol 46: 807-811.
16. Kay RM, Rethlefsen SA, Fern-Buneo A, Wren TA, Skaggs DL. (2004) Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy. J Bone Joint Surg Am 86-A: 2377-2384.
17. Heinen F, Molenaers G, Fairhurst C, Carr LJ, Desloovere K, Chaleat, Valayer E, Morel E, Papavassiliou AS, Tedroff K, Ignacio Pascual-Pascual S, et al. (2006) European consensus table 2006 on botulinum toxin for children with cerebral palsy. Eur J Paediatr Neurol 10: 215-225.
18. Koman LA, Mooney, JF 3rd, Smith, BP, Walker F, Leon JM. (2000) Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: A randomized, double-blind, placebo-controlled trial. BOTOX Study Group. J Pediatr Orthop 20: 108-115.
19. Bhatia KP, Munchau A, Thompson PD, Houser M, Chauhan VS, Hutchinson M, Shapira AH, Marsden CD. (1999) Generalised muscular weakness after botulinum toxin injections for dystonia: A report of three cases. J Neurol Neurosurg Psychiatry 67: 90-93.
20. Chen CM, Stott NS, Smith HK. (2002) Effects of botulinum toxin A injection and exercise on the growth of juvenile rat gastrocnemius muscle. J Appl Physiol 93: 1437-1447.